Gainers
- Tenax Therapeutics, Inc TENX shares rose 172.8% to $4.61 in pre-market trading. Tenax was granted a Notice of Allowance for U.S. Patent application for use of IV levosimendan in pulmonary hypertension with heart failure and preserved ejection fraction.
- ZyVersa Therapeutics, Inc. ZVSA shares rose 113% to $3.80 in pre-market trading after dropping 4% on Wednesday.
- Corbus Pharmaceuticals Holdings, Inc. CRBP shares rose 58.7% to $0.26 in pre-market trading after gaining over 5% on Wednesday.
- Carvana Co. CVNA rose 26.3% to $17.12 in pre-market trading after gaining 33% on Wednesday.
- Meta Platforms Inc. META rose 18.89% to $182.05 in pre-market trading after Piper Sandler analysts upgraded the stock to Overweight and raised its price target to $215.
- Silvergate Capital Corp SI shares rose 16.31% to $18.89 in pre-market trading after BlackRock disclosed an increased stake in the company.
- Align Technology, Inc. ALGN rose 12.61% to $318.18 in pre-market trading after the company reported better-than-expected results and announced a share buyback.
- Nuburu, Inc. BURU shares rose 33.02% to $13.09 in pre-market trading.
- Amazon.com, Inc. AMZN rose 4.27% to $109.64 in pre-market trading ahead of its quarterly report.
Losers
- NetGear, Inc. NTGR declined 12.27% to $18.03 in pre-market trading even after the company reported quarterly earnings and sales ahead of expectations.
- Naas Technology Inc NAAS declined 5.72% to $5.44 in pre-market trading.
- ING Groep NV INGA declined 4.79% to $13.94 in pre-market trading.
- HUYA Inc. - ADR HUYA declined 3.85% to $6.00 in pre-market trading, after rising more than 10% on Wednesday.
- VEON Ltd. VEON declined 3.34% to $0.58 in pre-market trading.
- Hyzon Motors Inc. HYZN declined 3.29% to $2.06 in pre-market trading, after the company said the board said Craig Knight's departure should constitute termination for cause under Knight's employment agreement.
- Compass Inc. COMP declined 3.18% to $4.27 in pre-market trading.
- ABB Ltd. ABB declined 3.09% to $34.24 in pre-market trading after the company guided to double-digit comparable revenue growth in the first quarter and comparable revenue growth above 5% for fiscal 2023.
- ChampionX Corp. CHX declined 3.08% to $31.5 in pre-market trading after the company reported quarterly sales of $985.86 million short of the consensus estimate of $1.01 billion.
- Corteva Inc. CTVA declined 2.75% to $62.71 in pre-market trading after the company announced disappointing guidance for fiscal 2023.
Now Read This: Investor Optimism Improves Ahead Of Fed's Decision
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in